Serial #79228152
LIVE

Serial Number

79228152

Owner

Mapix S.à.r.l

Filing Date

Mar 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79228152 Trademark

Serial Number: 79228152 • Registration: 5558018

Serial #79228152 is a trademark filed by Mapix S.à.r.l on March 30, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Mapix S.à.r.l (6 trademarks)

32-36, Boulevard d'Avranches

Entity Type: 99

Trademark Details

Filing Date

March 30, 2017

Registration Date

September 11, 2018

Published for Opposition

June 26, 2018

Cancellation Date

March 28, 2025

Goods & Services

Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical antitussive-cold preparations, preparations for treating colds and flu, preparations for preventing colds and flu, preparations for relief of cold and flu symptoms such as nasal congestion, cough and fever, and preparations for shortening the durations of colds and flu; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical use and veterinary use; food for babies; dietary supplements for humans and animals; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, and adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, and espiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based drugs pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; Pharmaceutical preparations, namely, immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infectious diseases

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 28, 2025 INTR
CANCELLED SECTION 71
Mar 28, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 11, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 11, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 21, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 20, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 11, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 11, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 26, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 26, 2018 PUBO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 7, 2018 ADCH
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 6, 2018 NONP
ASSIGNED TO LIE
May 21, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 11, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 11, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 11, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 11, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2018 TROA
REFUSAL PROCESSED BY IB
Apr 6, 2018 RFNT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2018 TCCA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 17, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 13, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 10, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 9, 2018 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 8, 2018 REPR